AKT inhibitor MK2206, or AKT phosphorylation activator IGF-1, abolished the cell proliferation (a), migration (b), invasion (c) and apoptosis (d) of HCC cells which were transduced of ANXA11 vectors. The gene discussed is AKT1; the disease is hepatocellular carcinoma.